Study Stopped
The study was terminated due to the COVID-19 situation.
Hangzhou Hospital Staff Cohort
HHSC
1 other identifier
observational
N/A
1 country
1
Brief Summary
The Hangzhou Hospital Staff Cohort (HHSC) is a prospective cohort study among staffs from three hospitals located in Hangzhou, China, including the Hangzhou First People's Hospital, Hangzhou Women's Hospital, and Hangzhou Red Cross Hospital. Participants recruitment and baseline survey including anthropometric, lifestyle and clinical measurement, as well as biological samples collection are initiated in January 2021. Recruited hospital staff are followed up every year during the medical examination organized by their employer. The primary aim of the HHSC study is to investigate the prospective associations of diet, physical activities, sleep, and other lifestyle factors with the long-term metabolic health of the hospital staffs. The secondary aim of the HHSC study is to integrate multi-omics data including genomics, metabolomics, proteomics and microbiome by a machine learning algorithm, to probe into the complex mediating roles of gene, metabolism and gut microbiota linking lifestyle factors with metabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2020
CompletedFirst Submitted
Initial submission to the registry
April 5, 2021
CompletedFirst Posted
Study publicly available on registry
June 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
June 13, 2025
May 1, 2025
9 years
April 5, 2021
June 10, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Incidence of type 2 diabetes diagnosed as fasting blood glucose larger than 7.0 mmol/L
Fasting blood glucose is measured every year during follow-up
3 years after enrollment
Incidence of type 2 diabetes diagnosed as fasting blood glucose larger than 7.0 mmol/L
Fasting blood glucose is measured every year during follow-up
6 years after enrollment
Incidence of type 2 diabetes diagnosed as fasting blood glucose larger than 7.0 mmol/L
Fasting blood glucose is measured every year during follow-up
9 years after enrollment
Secondary Outcomes (3)
Change of body mass index
Change from baseline at 3 years
Change of body mass index
Change from baseline at 6 years
Change of body mass index
Change from baseline at 9 years
Interventions
lifestyle factors
Eligibility Criteria
Patients who are serving staffs from the Hangzhou Frirst People's Hospital, Hangzhou Women's Hospital, and Hangzhou Red Cross Hospital are recruited.
You may qualify if:
- Participants aged 18 years or older
- Serving staffs of designated hospitals
You may not qualify if:
- Participants with cancer
- Participants with other serious medical disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Westlake Universitylead
- First People's Hospital of Hangzhoucollaborator
- Hangzhou Women's Hospitalcollaborator
- Red Cross Hospital, Hangzhou, Chinacollaborator
Study Sites (1)
Hangzhou First People's Hospital
Hangzhou, Zhejiang, 310058, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 9 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2021
First Posted
June 2, 2021
Study Start
December 30, 2020
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
June 13, 2025
Record last verified: 2025-05